11968 related articles for article (PubMed ID: 11887237)
1. [Sensitivity and specificity of screening cutaneous pre-malignant and malignant lesions].
Rocha FP; Menezes AM; Almeida HL; Tomasi E
Rev Saude Publica; 2002 Feb; 36(1):101-6. PubMed ID: 11887237
[TBL] [Abstract][Full Text] [Related]
2. Significance of dermoscopic patterns in detecting malignant melanoma on acral volar skin: results of a multicenter study in Japan.
Saida T; Miyazaki A; Oguchi S; Ishihara Y; Yamazaki Y; Murase S; Yoshikawa S; Tsuchida T; Kawabata Y; Tamaki K
Arch Dermatol; 2004 Oct; 140(10):1233-8. PubMed ID: 15492186
[TBL] [Abstract][Full Text] [Related]
3. False-negative findings in skin cancer and melanoma screening.
Rampen FH; Casparie-van Velsen JI; van Huystee BE; Kiemeney LA; Schouten LJ
J Am Acad Dermatol; 1995 Jul; 33(1):59-63. PubMed ID: 7601947
[TBL] [Abstract][Full Text] [Related]
4. Increasing Frequency of Seborrheic Keratosis Diagnoses as a Favorable Consequence of Teledermatology-Based Skin Cancer Screening: A Cross-sectional Study of 34,553 Patients.
Moreno-Ramírez D; Raya-Maldonado J; Morales-Conde M; Ojeda-Vila T; Martín-Gutiérrez FJ; Ruíz-de-Casas A; Fernández-Orland A; Jm HE; Ferrándiz L
Am J Clin Dermatol; 2017 Oct; 18(5):681-685. PubMed ID: 28397109
[TBL] [Abstract][Full Text] [Related]
5. Feasibility of targeted early detection for melanoma: a population-based screening study.
Melia J; Harland C; Moss S; Eiser JR; Pendry L
Br J Cancer; 2000 May; 82(9):1605-9. PubMed ID: 10789732
[TBL] [Abstract][Full Text] [Related]
6. Screening for cutaneous malignant melanoma: a feasibility study.
Törnberg S; Månsson-Brahme E; Lindén D; Ringborg U; Krakau I; Kärnell R; Landegren J; Brandberg Y; Hakulinen T
J Med Screen; 1996; 3(4):211-5. PubMed ID: 9041488
[TBL] [Abstract][Full Text] [Related]
7. Screening for malignant melanoma: A cost-effectiveness analysis.
Freedberg KA; Geller AC; Miller DR; Lew RA; Koh HK
J Am Acad Dermatol; 1999 Nov; 41(5 Pt 1):738-45. PubMed ID: 10534637
[TBL] [Abstract][Full Text] [Related]
8. [Importance of dermatologic screening within the frame work of a general cancer prevention program].
Lacava V; Salesi N; Ferrone L; Veri A; Lembo R; Masi MC; Rocchi M; Rondinelli R; Parisi E; Grieco T; Balzani A; Clerico R; Innocenzi D; Bottoni U; Calvieri S
Minerva Med; 2001 Apr; 92(2):85-8. PubMed ID: 11323570
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of skin cancer screening for individuals age 14 to 34 years.
Schmitt J; Seidler A; Heinisch G; Sebastian G
J Dtsch Dermatol Ges; 2011 Aug; 9(8):608-16. PubMed ID: 21501381
[TBL] [Abstract][Full Text] [Related]
10. Screening for Skin Cancer in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
Wernli KJ; Henrikson NB; Morrison CC; Nguyen M; Pocobelli G; Blasi PR
JAMA; 2016 Jul; 316(4):436-47. PubMed ID: 27458949
[TBL] [Abstract][Full Text] [Related]
11. Skin cancer screening campaign in the German speaking Community of Belgium.
Nikkels AF; Nikkels-Tassoudji N; Jerusalem-Noury E; Sandman-Lobusch H; Sproten G; Zeimers G; Schroeder J; Piérard GE
Acta Clin Belg; 2004; 59(4):194-8. PubMed ID: 15597726
[TBL] [Abstract][Full Text] [Related]
12. Total-Body Examination vs Lesion-Directed Skin Cancer Screening.
Hoorens I; Vossaert K; Pil L; Boone B; De Schepper S; Ongenae K; Annemans L; Chevolet I; Brochez L
JAMA Dermatol; 2016 Jan; 152(1):27-34. PubMed ID: 26466155
[TBL] [Abstract][Full Text] [Related]
13. Sensitivity, specificity, and diagnostic accuracy of three dermoscopic algorithmic methods in the diagnosis of doubtful melanocytic lesions: the importance of light brown structureless areas in differentiating atypical melanocytic nevi from thin melanomas.
Annessi G; Bono R; Sampogna F; Faraggiana T; Abeni D
J Am Acad Dermatol; 2007 May; 56(5):759-67. PubMed ID: 17316894
[TBL] [Abstract][Full Text] [Related]
14. Electrical impedance spectroscopy as a potential adjunct diagnostic tool for cutaneous melanoma.
Mohr P; Birgersson U; Berking C; Henderson C; Trefzer U; Kemeny L; Sunderkötter C; Dirschka T; Motley R; Frohm-Nilsson M; Reinhold U; Loquai C; Braun R; Nyberg F; Paoli J
Skin Res Technol; 2013 May; 19(2):75-83. PubMed ID: 23350668
[TBL] [Abstract][Full Text] [Related]
15. Computer-aided dermoscopy for diagnosis of melanoma.
Barzegari M; Ghaninezhad H; Mansoori P; Taheri A; Naraghi ZS; Asgari M
BMC Dermatol; 2005 Jul; 5():8. PubMed ID: 16000171
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of melanoma/skin cancer screening in Massachusetts. Preliminary results.
Koh HK; Caruso A; Gage I; Geller AC; Prout MN; White H; O'Connor K; Balash EM; Blumental G; Rex IH
Cancer; 1990 Jan; 65(2):375-9. PubMed ID: 2295061
[TBL] [Abstract][Full Text] [Related]
17. A two-stage validation study for determining sensitivity and specificity.
Tosteson TD; Titus-Ernstoff L; Baron JA; Karagas MR
Environ Health Perspect; 1994 Nov; 102 Suppl 8(Suppl 8):11-4. PubMed ID: 7851324
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of premalignant and malignant skin lesions in oculocutaneous albinism patients.
Ramos AN; Ramos JGR; Fernandes JD
Rev Assoc Med Bras (1992); 2021 Jan; 67(1):77-82. PubMed ID: 34161467
[TBL] [Abstract][Full Text] [Related]
19. Pre-diagnostic digital imaging prediction model to discriminate between malignant melanoma and benign pigmented skin lesion.
Christensen JH; Soerensen MB; Linghui Z; Chen S; Jensen MO
Skin Res Technol; 2010 Feb; 16(1):98-108. PubMed ID: 20384888
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
